Aberdeen Asset Management PLC UK raised its holdings in Ambev S.A. (NYSE:ABEV) by 65.0% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 5,555,409 shares of the company’s stock after purchasing an additional 2,188,000 shares during the period. Aberdeen Asset Management PLC UK’s holdings in Ambev were worth $30,499,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also made changes to their positions in the company. Great West Life Assurance Co. Can purchased a new position in shares of Ambev during the first quarter valued at approximately $427,000. Commerzbank Aktiengesellschaft FI lifted its stake in shares of Ambev by 30.4% during the first quarter. Commerzbank Aktiengesellschaft FI now owns 109,334 shares of the company’s stock valued at $630,000 after buying an additional 25,508 shares during the period. Advisors Asset Management Inc. lifted its stake in shares of Ambev by 19.2% during the first quarter. Advisors Asset Management Inc. now owns 113,783 shares of the company’s stock valued at $655,000 after buying an additional 18,343 shares during the period. DekaBank Deutsche Girozentrale lifted its stake in shares of Ambev by 78.1% during the first quarter. DekaBank Deutsche Girozentrale now owns 57,000 shares of the company’s stock valued at $330,000 after buying an additional 25,000 shares during the period. Finally, US Bancorp DE lifted its stake in shares of Ambev by 16.2% during the first quarter. US Bancorp DE now owns 423,319 shares of the company’s stock valued at $2,439,000 after buying an additional 58,955 shares during the period. 7.29% of the stock is currently owned by institutional investors.
Ambev S.A. (ABEV) opened at 6.43 on Friday. The company’s 50 day moving average is $6.17 and its 200 day moving average is $5.80. The stock has a market cap of $101.00 billion, a P/E ratio of 26.90 and a beta of 0.66. Ambev S.A. has a 52 week low of $4.70 and a 52 week high of $6.48.
Ambev (NYSE:ABEV) last released its earnings results on Thursday, July 27th. The company reported $0.04 earnings per share for the quarter, hitting the consensus estimate of $0.04. The business had revenue of $3.20 billion for the quarter, compared to the consensus estimate of $3.33 billion. Ambev had a net margin of 27.14% and a return on equity of 23.24%. Equities analysts predict that Ambev S.A. will post $0.23 earnings per share for the current year.
Several equities analysts recently issued reports on the stock. Zacks Investment Research downgraded shares of Ambev from a “buy” rating to a “hold” rating in a research note on Monday, July 31st. Barclays PLC reissued a “hold” rating on shares of Ambev in a research note on Sunday, July 30th. Three equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. Ambev currently has a consensus rating of “Buy” and an average target price of $6.10.
Ambev SA, formerly Inbev Participacoes Societarias SA, is a Brazil-based company engaged in the brewing sector. The Company produces and sells beer, carbonated soft drinks (CSDs) and other non-alcoholic and non-carbonated (NANC) beverages across the Americas. The Company’s activities are divided into three segments: Latin America North, including sell of beer, CSD and NANC drinks in Brazil, as well as operations in Dominican Republic, Saint Vincent, Antigua, Dominica, Guatemala, El Salvador, Nicaragua and Cuba; Latin America South, distributing products in Argentina, Bolivia, Paraguay, Uruguay, Chile, Ecuador, Peru and Colombia, and Canada, represented by Labatt’s operations, which comprises sales in Canada.
Receive News & Ratings for Ambev S.A. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ambev S.A. and related companies with MarketBeat.com's FREE daily email newsletter.